Ambu EBITDA Margin 2022-2024 | AMBBY

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Ambu (AMBBY) over the last 10 years. The current EBITDA margin for Ambu as of June 30, 2024 is .
Ambu EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-06-30 $0.76B $0.14B 18.22%
2024-03-31 $0.74B $0.13B 17.21%
2023-12-31 $0.71B $0.10B 14.51%
2023-09-30 $0.69B $0.09B 13.43%
2023-06-30 $0.66B $0.06B 9.53%
2023-03-31 $0.65B $0.05B 7.88%
2022-12-31 $0.65B $0.05B 8.06%
2022-09-30 $0.65B $0.05B 7.42%
Sector Industry Market Cap Revenue
Medical Medical - Hospitals $3.966B $0.784B
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics and rescue services. It provides anaesthesia, and patient monitoring and diagnostics products. Ambu A/S is based in Ballerup, Denmark.
Stock Name Country Market Cap PE Ratio
HCA Healthcare (HCA) United States $88.482B 16.02
Tenet Healthcare (THC) United States $15.494B 14.63
Universal Health Services (UHS) United States $13.526B 13.65
Acadia Healthcare (ACHC) United States $3.700B 11.35
Community Health Systems (CYH) United States $0.561B 0.00